ACTA SCIENTIFIC CLINICAL CASE REPORTS

Editorial Volume 5 Issue 5

AI and Clinical Trials: Recent Advances

Kaushal Kapadia*

Ph. D. Clinical Research, A Clinical Research Professional, Mumbai, Maharashtra, India

*Corresponding Author: Kaushal Kapadia, Ph. D. Clinical Research, A Clinical Research Professional, Mumbai, Maharashtra, India.

Received: March 05, 2024; Published: April 01, 2024

Abstract

Artificial Intelligence (AI) has made tremendous advances in the field of clinical trials, offering the potential to address key challenges and transform the landscape of drug development. Recent developments have shown that AI, combined with big data, can lead to faster and more precise drug development, improved patient care, and enhanced regulatory oversight.

References

  1. https://www.iconplc.com/insights/digital-disruption/ai-and-clinical-trials
  2. https://www.forbes.com/sites/greglicholai/2023/09/18/ai-in-clinical-research-now-and-beyond/?sh=118ad1353c85
  3. https://www.reuters.com/technology/big-pharma-bets-ai-speed-up-clinical-trials-2023-09-22/
  4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974218/
  5. https://acrpnet.org/2023/06/forward-thinking-for-the-integration-of-ai-into-clinical-trials/
  6. https://www.genengnews.com/topics/artificial-intelligence/ai-in-clinical-trials-reality- versus-hype/
  7. https://www.mckinsey.com/industries/life-sciences/our-insights/how-artificial-intelligence-can-power-clinical-development
  8. https://www.thelancet.com/journals/landig/article/PIIS2589-7500(20)30160-6/fulltext
  9. https://www.thelancet.com/journals/landig/article/PIIS2589-7500(20)30003-0/fulltext?amp=1
  10. https://www.sciencedirect.com/science/article/pii/S221315821630122
  11. https://www.nature.com/articles/s42256-019-0019-2

Citation

Citation: Kaushal Kapadia. “AI and Clinical Trials: Recent Advances".Acta Scientific Clinical Case Reports 5.5 (2024): 01-02.

Copyright

Copyright: © 2024 Kaushal Kapadia. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days
Impact Factor1.014

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US